Eli Lilly and Company

The organizational chart for Eli Lilly and Company is led by Dave Ricks, who serves as Chair and Chief Executive Officer. Under his leadership, the company's executive team oversees a broad range of business units and corporate functions. Reporting directly to Mr. Ricks are Anne White, President of Lilly Neuroscience; Jacob Van Naarden, President; Ilya Yuffa, President of Lilly USA and Global Customer Capabilities; and Daniel Skovronsky, Senior Vice President and Chief Scientific Officer. Eli Lilly's executive leadership also includes several key officers managing specialized functions. Eric Dozier serves as Executive Vice President and Chief People Officer, leading the Human Resources function. The Product function is headed by Jill Emerick, who holds the title of Executive Director, Product Management, and also oversees the Product Management sub-function. The Information Technology function is managed by Diogo Rau, who serves as Executive Vice President and Chief Digital and Information Officer. Under Mr. Rau, the IT organization comprises several sub-functions: Enterprise Architecture, led by Tim Coleman, Senior Vice President and Chief Technology Officer, with Maggie Madden serving as Senior Director and Chief of Staff for the CTO Organization; Digital Transformation and Innovation, led by Rich Carter, Senior Vice President and Chief Digital Officer, and Dave Beckman, Executive Director of Digital Transformation; Data Management and Analytics, led by Antonio Costa, Executive Director of Global Data Strategy and Delivery; Information Security, led by Andrea Abell, Chief Information Security Officer, which includes the Data Privacy & Security sub-function managed by Nick Merker, Vice President, Assistant General Counsel, Chief Privacy Officer and Head of the Digital Legal Office, and the Identity and Access Management sub-function managed by Daniel Palmeter, Executive Director of Cybersecurity Engineering, Identity Authentication Services Lead; and Manufacturing Technology, led by Floyd Springer, Executive Director of IT for Manufacturing and Quality in Puerto Rico. Additional IT leaders reporting directly to Mr. Rau include Xiangnan Dang, Executive Director of R&D IT, and DeAnna Zacherl, Director of Research, Information Technology. The Finance function is led by Lucas Montarce, Executive Vice President and Chief Financial Officer. Reporting to Mr. Montarce are numerous finance leaders, including Ilissa Rassner, Chief Financial Officer for Cardiometabolic Health and Immunology; Kecia Patton, Vice President and Chief Financial Officer for the Neuroscience Business Unit; Mark Stempel, Senior Vice President and Chief Financial Officer for Lilly USA; Fadi Debes, Senior Vice President and Chief Financial Officer for International; Nikki Miller, Chief Financial Officer and Associate Vice President for the Germany Hub; Lindsay Meade, Senior Director of Finance and Chief Financial Officer for Taiwan; Peter Hoogerhuis, Chief Financial Officer and Executive Director for the Global Commercial Oncology Business Unit; Michael Thompson, Chief Financial Officer for Lilly Oncology and Lilly Neuroscience; Lynamar Ortiz, Senior Director and Chief Financial Officer for Colombia; Ivan Chiao, Chief Financial Officer and Senior Finance Director for Brazil; Jarlath O'Malley, Associate Vice President, Chief Financial Officer and Head of Business Development for Latin America; Ping Fu, Chief Financial Officer for Global Services Finance; and Hong Yan, Senior Director of Finance and Procurement and Chief Financial Officer for the Kenosha Site. The Finance function also includes the Internal Audit sub-function, led by Jason Thompson, Executive Director of Corporate Audit Services. The Risk Management function is led by Michael Russo, Executive Director of Eli Lilly and Company Global Security for International Operations. The Operations function is managed by Verna Schmidlkofer, Chief Operations Officer, with additional leaders Megan Farrell, Executive Director and Chief Operating Officer for Clinical Development and Design, and Sandra Pinkney, Chief Operating Officer for Immunology in the United States. The Manufacturing function is led by Edgardo Hernandez, President of Global Manufacturing. Within this function, the Plant Operations sub-function is managed by James Peterson, Executive Director of Parenteral Manufacturing Operations for the Insulin Plant. The Supply Chain function is led by Erin H., Executive Director of Global Supply Chain. The Compliance function is headed by Stephanie McCallum, Group Vice President and Chief Ethics and Compliance Officer. Finally, the Quality Assurance function is led by Melissa Seymour, Executive Vice President and Chief Quality Officer.